Just caught Azenta's Q1 earnings and yeah, the market is not happy. Stock is tanking about 22% this morning after they reported that EPS miss. They posted a loss of $0.34 per share versus $0.25 last year, so the EPS deterioration is pretty significant. That's the kind of earnings surprise that triggers immediate selloff. Stock is now sitting around $28.78, down over $8 from yesterday's close. Revenue barely budged though - went from $147M to $149M, so the issue is really on the bottom line, not top line growth. The EPS beat/miss is usually what moves biotech and life science stocks like this, and clearly investors weren't expecting that kind of EPS weakness. Stock's been ranging between $23 and $55 over the past year, so we're getting closer to the lower end of that range now.